Dr Ambrish Mithal @DrAmbrishMithal · 05 Sep 2026
North America and Europe have been struggling to ease access of #GLP1 drugs to patients but the cost has been a major deterrent. The @bmj_latest points out that the availability of generic semaglutide at much lower cost is changing the situation. It also says that India leads
1 409Views
16Likes
3Reposts
0Replies
1Quotes
1Bookmarks
Is that a lot?
0.93×vs this author's median1 510 views is typical
38Percentile for this authorof 8 recent posts
0.80×vs 10K–100K median1 756 views is typical
2.75%Reachviews ÷ followers
1.42%Engagement rateof viewers reacted